5asa 250 mg/1 tableta gastrorezistentna tableta
pharmavision bh d.o.o. - месалазин - gastrorezistentna tableta - 250 mg/1 tableta - 1 gastrorezistentna tableta sadrži: 250 mg mesalazina
sulfasalazin krka en 500 mg/1 tableta gastrorezistentna tableta
krka farma d.o.o. sarajevo - sulfasalazin - gastrorezistentna tableta - 500 mg/1 tableta - 1 gastrorezistentna tableta sadrži: 500 mg sulfasalazina
sulfasalazin krka en 500 mg/1 tableta gastrorezistentna tableta
krka farma d.o.o. sarajevo - sulfasalazin - gastrorezistentna tableta - 500 mg/1 tableta - 1 gastrorezistentna tableta sadrži: 500 mg sulfasalazina
cobalamin 500 µg/1 tableta filmom obložena tableta
farmavita d.o.o. sarajevo - mekobalamin - filmom obložena tableta - 500 µg/1 tableta - 1 filmom obložena tableta sadrži: 500 µg mekobalamina
deep heat rub 12.8 %/100 g+ 5.91 %/100 g+ 1.97 %/100 g+ 1.47 %/100 g krema
oktal pharma d.o.o. sarajevo - mentol, metilsalicilat, terpentinsko ulje, ulje eukaliptusa - krema - 12.8 %/100 g+ 5.91 %/100 g+ 1.97 %/100 g+ 1.47 %/100 g - 100 g kreme sadrži: 12,80 % metilsalicilata 5,91 % mentola, racemičnog 1,97 % eteričnog ulja eukaliptusa 1,47 % terpentinskog ulja
rivaroxaban accord
accord healthcare s.l.u. - rivaroksaban - acute coronary syndrome; coronary artery disease; peripheral arterial disease; venous thromboembolism; stroke; atrial fibrillation; pulmonary embolism - antitrombotska sredstva - prevencija venske tromboembolije (vte) u odraslih bolesnika koji se podvrgavaju izborni operacije zamjena kuka ili koljena. liječenje tromboze dubokih vena (dvt) i plućne embolije (ТЭЛА) i prevenciju recidiva dvt i ТЭЛА kod odraslih. (see section 4. 4 for haemodynamically unstable pe patients. liječenje tromboze dubokih vena (dvt) i plućne embolije (ТЭЛА) i prevenciju recidiva dvt i ТЭЛА kod odraslih. (see section 4. 4 za hemodinamski nestabilne ТЭЛА pacijenata). adultsprevention of stroke and systemic embolism in adult patients with non valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. liječenje tromboze dubokih vena (dvt) i plućne embolije (ТЭЛА) i prevenciju recidiva dvt i ТЭЛА kod odraslih. (see section 4. 4 for haemodynamically unstable pe patients. )paediatric populationtreatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. rivaroxaban accord, co administered with acetylsalicylic acid (asa) alone or with asa plus ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers (see sections 4. 3, 4. 4 i 5. rivaroxaban accord, co administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events. adultsprevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. liječenje tromboze dubokih vena (dvt) i plućne embolije (ТЭЛА) i prevenciju recidiva dvt i ТЭЛА kod odraslih. (see section 4. 4 for haemodynamically unstable pe patients. )paediatric populationtreatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.
bcg-medac prašak i otapalo za intravezikalnu suspenziju
medac gesellschaft für klinische spezialpräparate mbh, theaterstraße 6, wedel, njemačka - bakterija bcg (bacillus calmette guérin), soj rivm (izveden iz soja 1173-p2 (živa, atenuirana)) - prašak i otapalo za intravezikalnu suspenziju - 2x10^8 do 3x10^9 vijabilnih jedinica - urbroj: nakon rekonstitucije jedna bočica sadrži: bcg (bacillus calmette guérin) bakterija mycobacterium bovis, živa, atenuirana, soj rivm izveden iz soja 1173-p2: 2x10^8 do 3x10^9 vijabilnih jedinica
trauma cold mast 5 g/100 g+ 1.5 g/100 g+ 1.5 g/100 g mast
viennapharm d.o.o. - kamfor, mentol, metilsalicilat - mast - 5 g/100 g+ 1.5 g/100 g+ 1.5 g/100 g - 100 g masti sadrži: 5 g metil salicilat 1,5 g mentol 1,5 g kamfor
trauma cold mast 5 g/100 g+ 1.5 g/100 g+ 1.5 g/100 g mast
viennapharm d.o.o. - kamfor, mentol, metilsalicilat - mast - 5 g/100 g+ 1.5 g/100 g+ 1.5 g/100 g - 100 g masti sadrži: 5 g metil salicilat 1,5 g mentol 1,5 g kamfor
trauma hot mast 5 g/100 g+ 5 g/100 g+ 0.91 g/100 g mast
viennapharm d.o.o. - ekstrakt ljute paprike, metilsalicilat, terpentinsko ulje - mast - 5 g/100 g+ 5 g/100 g+ 0.91 g/100 g - 100 g masti sadrži: 5 g metil salicilat 5 g terpentinsko ulje 0,91 g ekstrakt ljute paprike